Visual-spatial and Visual-perceptual Disorders Following Cerebellar Strokes

Stroke, Ischemic Clinical Trial

— VISUO-CEREBRO  

Official title:

Visual-spatial and Visual-perceptual Disorders Following Cerebellar Strokes

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04920461
• Other study ID #: P/2019/423
• Status: Recruiting
• Phase: N/A
• Start date: April 16, 2020
• Est. completion date: July 2021

Study information

• Verified date: June 2021
• Source: Centre Hospitalier Universitaire de Besancon
• Contact: Alice VOILLY, MD
• Phone: 0033381668236
• Email: avoilly[@]chu-besancon.fr
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aims at assessing the proportion of patients suffering from neuro-visual troubles (visual-spatial and/or visual-perceptual ), after cerebellar strokes.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 42
• Est. completion date: July 2021
• Est. primary completion date: July 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Signed informed consent form

• Being able to pass initial neuropsychological tests within 10 days after stroke

Exclusion Criteria:

• Previous central neural system/psychiatric/eye disease (including severe cranial trauma)

• Chronic alcoholism

• MRI contraindication.

Related Conditions & MeSH terms

• Perceptual Disorders
• Stroke
• Stroke, Ischemic

Intervention

Device:
• Additional MRI sequences
Additional MRI sequences (3D T2 SPACE sequence, 4/5 minutes approximatively)

Other:
• Neuropsychological assessment
Neurovisual function assessed with neuropsychological tests

Locations

Country	Name	City	State
France	CHU de Besançon	Besançon

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire de Besancon

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Presence of Neuro-Visual Disorder	Presence of neuro-visual disorder will be confirmed by obtaining at least 2 pathological scores at following neuropsychological tests: Rey & Taylor figures (score from 0 to 36, maximum); Judgment of Line Orientation (score from 0 to 36, maximum); Weschler Adult Intelligence Scale (final score is intelligence quotient, with an average score is fixed at 100); Test of Attentional Performance; Visual Object and Space Perception Battery (eight tests each designed to assess a particular aspect of object or space perception, while minimising the involvement of other cognitive skills); Visual agnosia assesment protocole (noted on 10 points)	Month 3